摘要
To the Editor:Generalized pustular psoriasis(GPP)is a rare,life-threatening skin disease characterized by recurrent episodes of pustulation.Apremilast,a phosphodiesterase 4(PDE4)inhibitor,is a relatively new drug for the treatment of moderate to severe plaque psoriasis.Herein,we reported a patient of recurrent GPP possibly triggered by apremilast.
基金
This study was supported by grants from the National Natural Science Foundation of China(No.81773331)
CAMS Initiative for Innovative Medicine(No.2017-12M-3-020).
